Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis

INTRODUCTION: The aim of this 18-month retrospective study was to evaluate the differences in outcomes of denosumab with tumor necrosis factor (TNF) inhibitors (TNFis), tocilizumab (TCZ), or abatacept (ABT) treatment in osteoporosis (OP) patients with rheumatoid arthritis (RA). PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Takako, Nakamura, Yukio, Kato, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840187/
https://www.ncbi.nlm.nih.gov/pubmed/29535527
http://dx.doi.org/10.2147/TCRM.S156350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840187/
https://www.ncbi.nlm.nih.gov/pubmed/29535527
http://dx.doi.org/10.2147/TCRM.S156350

Ejemplares similares